INSPIRE Pipeline™ Shield Post Approval Study

Active, not recruitingOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2028

Conditions
Intracranial Aneurysm
Interventions
DEVICE

Treatment of Intracranial Aneurysms

Embolization of aneurysms using the Pipeline™ Flex Embolization Device with Shield Technology™

Trial Locations (16)

19104

Hospital of the University of Pennsylvania, Philadelphia

29605

Prisma Health, Greenville

30322

Emory University Hospital, Atlanta

32207

Baptist Medical Center Jacksonville, Jacksonville

35294

University of Alabama at Birmingham, Birmingham

40202

Norton Healthcare, Louisville

44195

The Cleveland Clinic Foundation, Cleveland

60201

Endeavor Health - Evanston Hospital, Evanston

63130

Washington University in Saint Louis, St Louis

73104

Oklahoma (OU) University Medical Center, Oklahoma City

75201

Baylor Scott & White Research Institute, Dallas

06510

Yale New Haven Hospital, New Haven

10016-6402

NYU Langone Medical Center, New York

10467-2401

Montefiore Medical Center, New York

17822-9800

Geisinger Medical Center, Danville

84132-0001

University of Utah Hospital, Salt Lake City

All Listed Sponsors
lead

Medtronic Neurovascular Clinical Affairs

INDUSTRY